ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AEMD vs NMTC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Aethlon Medical Inc. (NASDAQ) VS. NeuroOne Medical Technologies Corporation (NASDAQ) • 15-METRIC TALLY: AEMD 2 — NMTC 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AEMD VS. NMTC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AEMD NMTC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 56.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -46.50% — TIE /operating-margins <GO>
Net Profit Margin — -39.60% — TIE /net-margins <GO>
Revenue Growth (YoY) — 163.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 5/9 -2.00 NMTC /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.5 40.1 +13.45 AEMD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $8.9M $8.8M $23.8K AEMD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AEMD REV NMTC REV AEMD GROSS % NMTC GROSS % AEMD FCF NMTC FCF
FY 2025 $0 $9.1M — 56.5% -$7.0M -$2.9M
FY 2024 $0 $3.5M — 31.3% -$7.6M -$11.1M
FY 2023 $0 $2.0M — — -$10.1M -$12.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AEMD // BETA —
NMTC // BETA —